These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20181938)

  • 1. High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.
    Lin Z; Zhao Y; Chung CY; Zhou Y; Xiong N; Glatt CE; Isacson O
    FASEB J; 2010 Jul; 24(7):2191-200. PubMed ID: 20181938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.
    Lin Z; Walther D; Yu XY; Li S; Drgon T; Uhl GR
    Hum Mol Genet; 2005 May; 14(10):1393-404. PubMed ID: 15829504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.
    Glatt CE; Wahner AD; White DJ; Ruiz-Linares A; Ritz B
    Hum Mol Genet; 2006 Jan; 15(2):299-305. PubMed ID: 16339215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
    Li Q; Yan Z; Kuang Y; Zhou X; Jin L; He L; Sun X; Tao T; Wang L
    Hum Reprod; 2016 Sep; 31(9):2150-7. PubMed ID: 27354380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hVMAT2: A Target of Individualized Medication for Parkinson's Disease.
    Xiong N; Li N; Martin E; Yu J; Li J; Liu J; Lee DY; Isacson O; Vance J; Qing H; Wang T; Lin Z
    Neurotherapeutics; 2016 Jul; 13(3):623-34. PubMed ID: 27137201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association analysis of 300 genes identifies a risk haplotype in SLC18A2 for post-traumatic stress disorder in two independent samples.
    Solovieff N; Roberts AL; Ratanatharathorn A; Haloosim M; De Vivo I; King AP; Liberzon I; Aiello A; Uddin M; Wildman DE; Galea S; Smoller JW; Purcell SM; Koenen KC
    Neuropsychopharmacology; 2014 Jul; 39(8):1872-9. PubMed ID: 24525708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence.
    Schwab SG; Franke PE; Hoefgen B; Guttenthaler V; Lichtermann D; Trixler M; Knapp M; Maier W; Wildenauer DB
    Neuropsychopharmacology; 2005 Dec; 30(12):2263-8. PubMed ID: 15988470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.
    Crowley JJ; Lipsky RH; Lucki I; Berrettini WH
    Psychiatr Genet; 2008 Oct; 18(5):248-51. PubMed ID: 18797399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.
    Zai CC; Tiwari AK; Mazzoco M; de Luca V; Müller DJ; Shaikh SA; Lohoff FW; Freeman N; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Remington G; Kennedy JL
    J Psychiatr Res; 2013 Nov; 47(11):1760-5. PubMed ID: 24018103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.
    Sørensen KD; Wild PJ; Mortezavi A; Adolf K; Tørring N; Heebøll S; Ulhøi BP; Ottosen P; Sulser T; Hermanns T; Moch H; Borre M; Ørntoft TF; Dyrskjøt L
    Clin Cancer Res; 2009 Feb; 15(4):1400-10. PubMed ID: 19228741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two risk haplotypes for schizophrenia and bipolar disorder in the synaptic vesicle monoamine transporter gene (SVMT).
    Gutiérrez B; Rosa A; Papiol S; Arrufat FJ; Catalán R; Salgado P; Peralta V; Cuesta MJ; Fañanás L
    Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):502-7. PubMed ID: 17427184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals.
    Saida K; Maroofian R; Sengoku T; Mitani T; Pagnamenta AT; Marafi D; Zaki MS; O'Brien TJ; Karimiani EG; Kaiyrzhanov R; Takizawa M; Ohori S; Leong HY; Akay G; Galehdari H; Zamani M; Romy R; Carroll CJ; Toosi MB; Ashrafzadeh F; Imannezhad S; Malek H; Ahangari N; Tomoum H; Gowda VK; Srinivasan VM; Murphy D; Dominik N; Elbendary HM; Rafat K; Yilmaz S; Kanmaz S; Serin M; Krishnakumar D; Gardham A; Maw A; Rao TS; Alsubhi S; Srour M; Buhas D; Jewett T; Goldberg RE; Shamseldin H; Frengen E; Misceo D; Strømme P; Magliocco Ceroni JR; Kim CA; Yesil G; Sengenc E; Guler S; Hull M; Parnes M; Aktas D; Anlar B; Bayram Y; Pehlivan D; Posey JE; Alavi S; Madani Manshadi SA; Alzaidan H; Al-Owain M; Alabdi L; Abdulwahab F; Sekiguchi F; Hamanaka K; Fujita A; Uchiyama Y; Mizuguchi T; Miyatake S; Miyake N; Elshafie RM; Salayev K; Guliyeva U; Alkuraya FS; Gleeson JG; Monaghan KG; Langley KG; Yang H; Motavaf M; Safari S; Alipour M; Ogata K; Brown AEX; Lupski JR; Houlden H; Matsumoto N
    Genet Med; 2023 Jan; 25(1):90-102. PubMed ID: 36318270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association study of the vesicular monoamine transporter 1 (VMAT1) gene with autism in an Iranian population.
    Noroozi R; Ghafouri-Fard S; Omrani MD; Habibi M; Sayad A; Taheri M
    Gene; 2017 Aug; 625():10-14. PubMed ID: 28476685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.
    Watson F; Deavall DG; Macro JA; Kiernan R; Dimaline R
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):193-9. PubMed ID: 9882615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2.
    Gerhard M; Neumayer N; Presecan-Siedel E; Zanner R; Lengyel E; Cramer T; Höcker M; Prinz C
    Endocrinology; 2001 Aug; 142(8):3663-72. PubMed ID: 11459816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human dopamine transporter gene: differential regulation of 18-kb haplotypes.
    Zhao Y; Xiong N; Liu Y; Zhou Y; Li N; Qing H; Lin Z
    Pharmacogenomics; 2013 Sep; 14(12):1481-94. PubMed ID: 24024899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons.
    Hwang DY; Hong S; Jeong JW; Choi S; Kim H; Kim J; Kim KS
    J Neurochem; 2009 Dec; 111(5):1202-12. PubMed ID: 19780901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of the rat vesicular monoamine transporter 2 promoter in gastric epithelial cells: regulation by gastrin.
    Watson F; Kiernan RS; Deavall DG; Varro A; Dimaline R
    J Biol Chem; 2001 Mar; 276(10):7661-71. PubMed ID: 11113118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the
    Zhai H; Zheng Y; He Y; Zhang Y; Guo Z; Cui W; Sun L
    Int J Neurosci; 2023 May; 133(5):574-577. PubMed ID: 34078222
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene.
    Greenwood TA; Kelsoe JR
    Genomics; 2003 Nov; 82(5):511-20. PubMed ID: 14559208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.